Chronic bronchitis emphysema
Conditions
Interventions
swallow therapy
Sponsors
Maasstadziekenhuis
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: In order to be eligible to participate in this study, a subject must meet all of the following criteria: • COPD gold 2,3,4 with a Pulmonary Function Testing not older than 12 months • At least 2 proven moderate or severe COPD exacerbation in the last 2 years
Exclusion criteria
Exclusion criteria: other lungdisease active exacerbation COPD reduced learning because of congnitive impairment recent speech therapy (
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome measure is the number of moderate to severe exacerbations over a period of 12 months after allocation to treatment or control group. An exacerbation is defined as moderate if treatment with antibiotics or corticosteroid is initiated or dosage increase should be given. An exacerbation is defined as severe if a patient had to be hospitalized because of the exacerbation or dies. | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary outcome measure is patient swallowing satisfaction measured by the VAS (visual analog scale) and the dysphagia disability index. These are evaluated at baseline and after 12 months | — |
Countries
Netherlands
Outcome results
None listed